View in EDS HTML Full Text PDF Full Text

Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.

Saved in:
Bibliographic Details
Title: Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
Authors: Liu Z; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.; Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital Melbourne, Melbourne, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia., Martin JH; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia., Liauw W; Department of Medical Oncology, St. George's Hospital, Sydney, Australia., McLachlan SA; Department of Medical Oncology, St. Vincent's Hospital, Melbourne, Australia., Link E; Biostatistics and Clinical Trials Centre, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia., Matera A; Biostatistics and Clinical Trials Centre, Peter MacCallum Cancer Centre, Melbourne, Australia., Thompson M; Department of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia., Jefford M; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia., Hicks RJ; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.; Department of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia., Cullinane C; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Hatzimihalis A; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Campbell I; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.; Victorian Breast Cancer Research Cooperative (VBCRC) Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Crowley S; Previously Victorian Breast Cancer Research Cooperative (VBCRC) Cancer Genetics Laboratory, The Murdoch Children's Research Institute, The Royal Children's Hospital, Peter MacCallum Cancer Centre), MelbourneMelbourne, Australia., Beale PJ; Department of Medical Oncology, Concord and Royal Prince Alfred Hospital, Sydney, Australia., Karapetis CS; Department of Medical Oncology, Flinders Medical Centre, Flinders Centre for Innovation in Cancer, Adelaide, Australia., Price T; Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, Australia., Burge ME; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Australia., Michael M; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia. Michael.Michael@petermac.org.; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia. Michael.Michael@petermac.org.
Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Jan; Vol. 78 (1), pp. 53-64. Date of Electronic Publication: 2021 Sep 04.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34480602
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.; Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital Melbourne, Melbourne, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Martin+JH%22">Martin JH</searchLink>; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Liauw+W%22">Liauw W</searchLink>; Department of Medical Oncology, St. George's Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22McLachlan+SA%22">McLachlan SA</searchLink>; Department of Medical Oncology, St. Vincent's Hospital, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Link+E%22">Link E</searchLink>; Biostatistics and Clinical Trials Centre, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Matera+A%22">Matera A</searchLink>; Biostatistics and Clinical Trials Centre, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Thompson+M%22">Thompson M</searchLink>; Department of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Jefford+M%22">Jefford M</searchLink>; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.<br /><searchLink fieldCode="AU" term="%22Hicks+RJ%22">Hicks RJ</searchLink>; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.; Department of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Cullinane+C%22">Cullinane C</searchLink>; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Hatzimihalis+A%22">Hatzimihalis A</searchLink>; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Campbell+I%22">Campbell I</searchLink>; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia.; Victorian Breast Cancer Research Cooperative (VBCRC) Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Crowley+S%22">Crowley S</searchLink>; Previously Victorian Breast Cancer Research Cooperative (VBCRC) Cancer Genetics Laboratory, The Murdoch Children's Research Institute, The Royal Children's Hospital, Peter MacCallum Cancer Centre), MelbourneMelbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Beale+PJ%22">Beale PJ</searchLink>; Department of Medical Oncology, Concord and Royal Prince Alfred Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Karapetis+CS%22">Karapetis CS</searchLink>; Department of Medical Oncology, Flinders Medical Centre, Flinders Centre for Innovation in Cancer, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Price+T%22">Price T</searchLink>; Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Burge+ME%22">Burge ME</searchLink>; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Michael+M%22">Michael M</searchLink>; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, Australia. Michael.Michael@petermac.org.; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia. Michael.Michael@petermac.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%221256165%22">European journal of clinical pharmacology</searchLink> [Eur J Clin Pharmacol] 2022 Jan; Vol. 78 (1), pp. 53-64. <i>Date of Electronic Publication: </i>2021 Sep 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>1256165 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200316970%22">00316970 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34480602
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00228-021-03206-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 53
    Titles:
      – TitleFull: Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu Z
      – PersonEntity:
          Name:
            NameFull: Martin JH
      – PersonEntity:
          Name:
            NameFull: Liauw W
      – PersonEntity:
          Name:
            NameFull: McLachlan SA
      – PersonEntity:
          Name:
            NameFull: Link E
      – PersonEntity:
          Name:
            NameFull: Matera A
      – PersonEntity:
          Name:
            NameFull: Thompson M
      – PersonEntity:
          Name:
            NameFull: Jefford M
      – PersonEntity:
          Name:
            NameFull: Hicks RJ
      – PersonEntity:
          Name:
            NameFull: Cullinane C
      – PersonEntity:
          Name:
            NameFull: Hatzimihalis A
      – PersonEntity:
          Name:
            NameFull: Campbell I
      – PersonEntity:
          Name:
            NameFull: Crowley S
      – PersonEntity:
          Name:
            NameFull: Beale PJ
      – PersonEntity:
          Name:
            NameFull: Karapetis CS
      – PersonEntity:
          Name:
            NameFull: Price T
      – PersonEntity:
          Name:
            NameFull: Burge ME
      – PersonEntity:
          Name:
            NameFull: Michael M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022 Jan
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1432-1041
          Numbering:
            – Type: volume
              Value: 78
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: European journal of clinical pharmacology
              Type: main
ResultId 1